QR Code

Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study

ABSTRACT Objective The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. Subjects and methods We randomized 47 insulin-treated non-proteinuric patients with sat...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Sociedade Brasileira de Endocrinologia e Metabologia 2020-04-01
Rangatū:Archives of Endocrinology and Metabolism
Ngā marau:
Vildagliptin
type 2 diabetes
renal function
NGAL
cystatin C
type IV collagen
Urunga tuihono:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000400418&tlng=en
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite